These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 33290777)
1. Overexpression of FKH-2/FOXG1 is neuroprotective in a C. elegans model of Machado-Joseph disease. Fardghassemi Y; Parker JA Exp Neurol; 2021 Mar; 337():113544. PubMed ID: 33290777 [TBL] [Abstract][Full Text] [Related]
2. Small Molecule Rescue of ATXN3 Toxicity in C. elegans via TFEB/HLH-30. Fardghassemi Y; Maios C; Parker JA Neurotherapeutics; 2021 Apr; 18(2):1151-1165. PubMed ID: 33782863 [TBL] [Abstract][Full Text] [Related]
3. Rescue of ATXN3 neuronal toxicity in Fardghassemi Y; Tauffenberger A; Gosselin S; Parker JA Dis Model Mech; 2017 Dec; 10(12):1465-1480. PubMed ID: 29061563 [TBL] [Abstract][Full Text] [Related]
4. Functional genomics and biochemical characterization of the C. elegans orthologue of the Machado-Joseph disease protein ataxin-3. Rodrigues AJ; Coppola G; Santos C; Costa Mdo C; Ailion M; Sequeiros J; Geschwind DH; Maciel P FASEB J; 2007 Apr; 21(4):1126-36. PubMed ID: 17234717 [TBL] [Abstract][Full Text] [Related]
5. Druggable genome screen identifies new regulators of the abundance and toxicity of ATXN3, the Spinocerebellar Ataxia type 3 disease protein. Ashraf NS; Sutton JR; Yang Y; Ranxhi B; Libohova K; Shaw ED; Barget AJ; Todi SV; Paulson HL; Costa MDC Neurobiol Dis; 2020 Apr; 137():104697. PubMed ID: 31783119 [TBL] [Abstract][Full Text] [Related]
6. Autophagy in Spinocerebellar Ataxia Type 3: From Pathogenesis to Therapeutics. Paulino R; Nóbrega C Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108570 [TBL] [Abstract][Full Text] [Related]
7. Preimplantation Genetic Testing of Spinocerebellar Ataxia Type 3/Machado-Joseph Disease-Robust Tools for Direct and Indirect Detection of the Lian M; Tan VJ; Taguchi R; Zhao M; Phang GP; Tan AS; Liu S; Lee CG; Chong SS Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125643 [TBL] [Abstract][Full Text] [Related]
8. Inactivation of PNKP by mutant ATXN3 triggers apoptosis by activating the DNA damage-response pathway in SCA3. Gao R; Liu Y; Silva-Fernandes A; Fang X; Paulucci-Holthauzen A; Chatterjee A; Zhang HL; Matsuura T; Choudhary S; Ashizawa T; Koeppen AH; Maciel P; Hazra TK; Sarkar PS PLoS Genet; 2015 Jan; 11(1):e1004834. PubMed ID: 25590633 [TBL] [Abstract][Full Text] [Related]
9. Extracellular vesicle-based delivery of silencing sequences for the treatment of Machado-Joseph disease/spinocerebellar ataxia type 3. Rufino-Ramos D; Albuquerque PR; Leandro K; Carmona V; Martins IM; Fernandes R; Henriques C; Lobo D; Faro R; Perfeito R; Mendonça LS; Pereira D; Gomes CM; Nobre RJ; Pereira de Almeida L Mol Ther; 2023 May; 31(5):1275-1292. PubMed ID: 37025062 [TBL] [Abstract][Full Text] [Related]
10. Unravelling Endogenous MicroRNA System Dysfunction as a New Pathophysiological Mechanism in Machado-Joseph Disease. Carmona V; Cunha-Santos J; Onofre I; Simões AT; Vijayakumar U; Davidson BL; Pereira de Almeida L Mol Ther; 2017 Apr; 25(4):1038-1055. PubMed ID: 28236575 [TBL] [Abstract][Full Text] [Related]
11. Identification of the 5-HT Pereira-Sousa J; Ferreira-Lomba B; Bellver-Sanchis A; Vilasboas-Campos D; Fernandes JH; Costa MD; Varney MA; Newman-Tancredi A; Maciel P; Teixeira-Castro A Neurobiol Dis; 2021 May; 152():105278. PubMed ID: 33516872 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of NF-κB in astrocytes is sufficient to delay neurodegeneration induced by proteotoxicity in neurons. Li YX; Sibon OCM; Dijkers PF J Neuroinflammation; 2018 Sep; 15(1):261. PubMed ID: 30205834 [TBL] [Abstract][Full Text] [Related]
16. Silencing ataxin-3 mitigates degeneration in a rat model of Machado-Joseph disease: no role for wild-type ataxin-3? Alves S; Nascimento-Ferreira I; Dufour N; Hassig R; Auregan G; Nóbrega C; Brouillet E; Hantraye P; Pedroso de Lima MC; Déglon N; de Almeida LP Hum Mol Genet; 2010 Jun; 19(12):2380-94. PubMed ID: 20308049 [TBL] [Abstract][Full Text] [Related]